Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Eli Lilly and Company
LLYHealth technology
$928.6B
Market Cap
Shariah Analysis
Passed
Business
Cash
Liabilities
Based on AAOIFI screening standards, Eli Lilly and Company appears to be Passed.
Business Activity
FYE 2024
Non-Permissible Income (<5%)0.40%
Non-Permissible
$175
Total Income
$45.7K
Revenue Breakdown
Net product revenue
Pharmaceutical products
$40.7K
Collaboration and other revenue
Pharmaceutical products
$4.3K
Interest income
Non-Operating
$175
Non-Compliant: $175
Retirement benefit plans
Non-Operating
$462
Financial Screening
FYE 2024
Cash (<30%)0.53%
Non-Shariah Cash Items
Cash And Cash Equivalents$3.3B
Other Short Term Investments$154.8M
Held To Maturity Securities$211.4M
Liabilities (<30%)4.89%
Non-Shariah Liabilities
Long Term Debt$28.5B
Current Debt$5.1B
Market Data
Exchange
NYSE
CurrencyUSD
CountryUnited States
Last Updated2025-12-19
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
NYSE
